Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Gainers
Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Where Ocugen Stands With Analysts
Analysts have provided the following ratings for Ocugen (NASDAQ:OCGN) within the last quarter:
This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says
Mizuho initiated coverage on Ocugen Inc (NASDAQ:OCGN) with a Buy rating and a price target of $5, reflecting an upside of almost…
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell
• Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Earnings Outlook For Ocugen
Ocugen (NASDAQ:OCGN) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement.
Analysts estimate that Ocugen will report an earnings per share (EPS) of $-0.08.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Ocugen’s Partner COVID-19 Vaccine Covaxin Shows Encouraging Action In Children Below 18 Years
Ocugen Inc (NASDAQ:OCGN) announced the publication of positive pediatric Phase 2/3 study results in children aged 2–18 years for COVID-19 vaccine,…
Article in Nature Microbiology Says Inactivated Whole-Virion Vaccine BBV152/Covaxin Elicits Robust Cellular Immune Memory to Sarscov-2 and Variants of Concern
https://www.nature.com/articles/s41564-022-01161-5.epdf?sharing_token=MpVlYuz8TA0rxdAzKPCl4dRgN0jAjWel9jnR3ZoTv0Necl0DNKYADOncNjVs7G8t15n3d-5o5UT8C3h7PFGyI5wP-pGcIS0BSNaWdtcbST-tf-1sQ6-vrwJGiB9G1XRaDtivmvCcGn9EPx4TZvISApHl7L3rd1dRpyANfnDr9nQ%3D